Brief: Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones
06/03/2025 21:45
March 6 (Reuters) - Contineum Therapeutics Inc CTNM.O: CONTINEUM THERAPEUTICS INC: CASH RUNWAY PROJECTED THROUGH 2027 Source text: ID:nBw1V9sd4a Further company coverage: CTNM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Contineum Therapeutics
See all newsPREVIEW: Johnson & Johnson earnings expected to decline in Q3
PREVIEW: Johnson & Johnson earnings expected to decline in Q3
US STOCKS ON THE MOVE-Microsoft, Salesforce, Bristol Myers
US STOCKS ON THE MOVE-Microsoft, C3.ai, Salesforce, Bristol Myers
Contineum tumbles as Bristol's partial trial win raises dose doubts